Consumer Advisor

The Front Line COVID-19 Critical Care (FLCCC) Alliance was initially formed as a working group under “emergency” conditions of the early COVID-19 pandemic in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive mortality associated with the prevailing “supportive care only” recommendations disseminated by the majority of national and international health care organizations. Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About this Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. I

The uses of artificial intelligence (AI) in medicine have been growing in many areas, including in the analysis of medical images, (1) the detection of drug interactions, (2) the identification of high-risk patients, (3) and the coding of medical notes. (4) Several such uses of AI are the topics of the “AI in Medicine” review article series that debuts in this issue of the Journal. Here we describe another type of AI, the medical AI chatbot. AI Chatbot Technology A chatbot consists of two main components: a general-purpose AI system and a chat interface. This article considers specifically an AI system called GPT-4 (Generative Pretrained Transformer 4) with a chat interface; this system is widely available and in active development by OpenAI, an AI research and deployment company. 5 To use a chatbot, one starts a “session” by entering a query — usually referred to as a “prompt” — in plain natural language. Typically, but not always, the user is a human being. The ch